{"transactions":[{"id":3186188,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T17:23:13.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":2007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":2007,"derivative":{"exercise_price":2.48,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":2007},"source":{"system":"sec-edgar","filing":"0001578563-20-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856320000009/primary_doc.xml","form_type":"4"}},{"id":3326974,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-02T19:34:53.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":11016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":1106,"derivative":{"exercise_price":5.39,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":1106},"source":{"system":"sec-edgar","filing":"0001578563-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856320000003/primary_doc.xml","form_type":"4"}},{"id":3398337,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-03T17:46:03.000Z","date":"2019-08-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in full on August 7, 2020, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.93,"expiration_date":"2029-08-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001578563-19-000031","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000031/primary_doc.xml","form_type":"4"}},{"id":3400726,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-02T17:02:11.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":1819,"derivative":{"exercise_price":3.29,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":1819},"source":{"system":"sec-edgar","filing":"0001578563-19-000027","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000027/primary_doc.xml","form_type":"4"}},{"id":3470913,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-02T16:08:47.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1172,"derivative":{"exercise_price":5.44,"exercise_date":"2019-06-28","expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":1172},"source":{"system":"sec-edgar","filing":"0001104659-19-039025","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000110465919039025/a4.xml","form_type":"4"}},{"id":3571823,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-01T17:32:32.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1724,"derivative":{"exercise_price":5.84,"exercise_date":"2019-03-29","expiration_date":"2019-03-28","underlying":"Common Stock","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0001578563-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000008/primary_doc.xml","form_type":"4"}},{"id":3571822,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T17:32:32.000Z","date":"2017-06-09","kind":"purchase","acquired":true,"shares":10000,"price":0.42,"value":4200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001578563-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000008/primary_doc.xml","form_type":"4"}},{"id":3571821,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T17:32:32.000Z","date":"2016-12-10","kind":"purchase","acquired":true,"shares":10000,"price":1.07,"value":10700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001578563-19-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000008/primary_doc.xml","form_type":"4"}},{"id":3713013,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-02T16:39:41.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3095,"derivative":{"exercise_price":3.23,"exercise_date":"2018-12-31","expiration_date":"2028-12-30","underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001578563-19-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856319000003/primary_doc.xml","form_type":"4"}},{"id":3869792,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-07-11T19:48:04.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 500,000 shares of common stock are exercisable immediately, options to purchase 125,000 shares of common stock are exercisable on each of July 1, 2019 and July 1, 2020, options to purchase 125,000 shares of common stock shall vest on such date, if any, as the Issuer pays to the reporting person a bonus in the amount of $25,000 if the Issuer achieves net product revenue in the amount of not less than $1.2 million for the portion of the 2018 fiscal year following July 1, 2018, and options to purchase 125,000 shares of common stock shall vest on such date, if any, as the Issuer pays to the reporting person a bonus in the amount of $25,000 if the daily VWAP of the common stock of the Issuer is not less than $2.00 per share for a sixty consecutive day period beginning on any calendar day during the 2018 fiscal year on or after July 1, 2018."}],"balance_after":1000000,"derivative":{"exercise_price":0.66,"expiration_date":"2028-07-10","underlying":"common stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-18-009908","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218009908/ownership.xml","form_type":"4"}},{"id":3927762,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T19:51:27.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in full on May 15, 2019, subject to the grantee's continued service on such vesting date."}],"balance_after":8357,"derivative":{"exercise_price":3.71,"exercise_date":"2019-05-15","expiration_date":"2028-05-14","underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001578563-18-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291962/000157856318000009/primary_doc.xml","form_type":"4"}},{"id":4477372,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":150101,"kind":"person","name":"Hacksell Uli","position":1,"cik":"0001291962","reported_name":"Hacksell Uli","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-30T22:05:02.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33,333 of the shares underlying the option vested and became exercisable on the date of grant; 33,333 shares shall vest and become exercisable on the first anniversary of the date of grant, and 33,334 shares shall vest and become exercisable on the second anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":100000,"derivative":{"exercise_price":0.87,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-17-000406","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000156218017000406/primarydocument.xml","form_type":"4"}}]}